Panacea Index Logo

Command Palette

Search for a command to run...

Does a restricted energy low glycemic index diet have a different effect on overweight women with or without polycystic ovary syndrome?

BMC endocrine disorders
September 2, 2019
Farnaz Shishehgar et al. (5 authors)
Journal ArticleHuman Study
Study Details

Study Goal

The researchers aimed to compare the effects of a hypocaloric low glycemic index (LGI) diet on anthropometric variables and insulin resistance in women with and without PCOS, and to investigate its impact on clinical and hormonal features in PCOS women.

Results Summary

The LGI diet resulted in similar weight loss and improvements in insulin resistance for both PCOS and non-PCOS groups. PCOS women also showed significant reductions in testosterone and FAI, increased SHBG, and improvements in menstrual irregularity and acne.

Population

Obese women with (n=28) and without (n=34) polycystic ovary syndrome (PCOS).

Effective Dosage

Hypocaloric LGI diet (specific caloric intake not detailed).

Duration

24 weeks.

Interactions

None mentioned.

Extracted Claims (8)
InterventionDirectionEndpointPopulationDosageImpactClaim #
hypocaloric low glycemic index (LGI) diet
no change
percentages of weight loss
women with PCOS vs. women without PCOS
PCOS: -8.04% vs. non-PCOS: -8.09%
did not differ significantly
#1
hypocaloric low glycemic index (LGI) diet
decrease
homeostatic model assessment of insulin resistance (HOMA-IR)
women with PCOS vs. women without PCOS
PCOS = - 0.83 ± 0.33, non PCOS = - 0.79 ± 0.28
No significant difference in decrease
#2
hypocaloric low glycemic index (LGI) diet
decrease
total testosterone
women with PCOS
- 0.91 ± 0.33 nmol/L
significant reduction
#3
hypocaloric low glycemic index (LGI) diet
decrease
FAI
women with PCOS
- 4.47 ± 1.1
significant reduction
#4
hypocaloric low glycemic index (LGI) diet
increase
SHBG
women with PCOS
38.98 ± 11.02 nmol/L
increase
#5
hypocaloric low glycemic index (LGI) diet
increase
Menstrual irregularity
women with PCOS
80%
was improved
#6
hypocaloric low glycemic index (LGI) diet
decrease
occurrence of acne
women with PCOS
32.1%
significant decrease
#7
hypocaloric low glycemic index (LGI) diet
increase
anthropometric and metabolic characteristics
overweight women with and without PCOS
-
has equally beneficial effects
#8
Abstract

BACKGROUND: Obese women with polycystic ovary syndrome (PCOS) may face additional barriers in achieving weight loss. We aimed to compare the effects of the hypocaloric low glycemic index (LGI) diet on anthropometric variables and insulin resistance in women with and without PCOS and investigate the effect of this diet on the clinical and hormonal features of PCOS women. METHODS: This interventional study was carried out at the Reproductive Endocrinology Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Of 108 women invited for the purpose of the present study, 62 participants (PCOS = 28, non-PCOS = 34) followed a 24-week energy restricted LGI diet. Anthropometric, biochemical, hormonal and clinical measurements were documented at baseline, 12 weeks and 24 weeks with intervention. RESULTS: The percentages of weight loss achieved by both the PCOS and non-PCOS groups did not differ significantly (PCOS: -8.04% vs. non-PCOS: -8.09%). No significant difference in decrease of homeostatic model assessment of insulin resistance (HOMA-IR) was observed between the two groups (PCOS = - 0.83 ± 0.33, non PCOS = - 0.79 ± 0.28, P = 0.83). In PCOS women, significant reduction in total testosterone (- 0.91 ± 0.33 nmol/L, P = 0.006), FAI (- 4.47 ± 1.1, P < 0.001) and increase in SHBG (38.98 ± 11.02 nmol/L, P < 0.001) were observed. Menstrual irregularity was improved in 80% of women with PCOS and a significant decrease (32.1%) in occurrence of acne was reported. CONCLUSIONS: This diet has equally beneficial effects on anthropometric and metabolic characteristics of overweight women with and without PCOS. TRIAL REGISTRATION: This study is registered in the Iranian Randomized Clinical Trials Registry (IRCT, code: IRCT2016092129909N1 ).

Medical Subject Headings (MeSH)
AdolescentAdultBody Mass IndexCaloric RestrictionCase-Control StudiesDiet, ReducingFemaleFollow-Up StudiesGlycemic IndexHumansInsulin ResistanceObesityOverweightPolycystic Ovary SyndromePrognosisWeight LossYoung Adult
Study Links
Quality Scores
SafetyNot Assessed
Efficacy85/10
Quality75/10
Citation Metrics
Total Citations26
Citations/Year4.3
Relative Citation Ratio2.02
NIH Percentile74.8%
Research Impact Scores
APT Score0.75
Weight Score2.23
Normalized Score0.69
Related Supplements